Cord Blood America Inc. (OTCBB:CBAI) has gained 21.74% or $0.0005 to settle at $0.0028 with a volume of 69 million shares traded. The stock is trading below its 50 day moving average of $0.0039 and its 200 day moving average of $0.0047 with a relative strength index of 42.
Cord Blood America, Inc. (CBAI) is a holding company whose subsidiaries include Cord Partners, CorCell Co. Inc., CorCell Ltd., (Cord), CBA Professional Services, Inc. D/B/A BodyCells, Inc. (BodyCells), CBA Properties, Inc. (Properties) and Career Channel Inc, D/B/A Rainmakers International (Rain). It is engaged in the business activities of Cord, BodyCells, Properties and Rain. Cord specializes in providing private cord blood stem cell preservation services to families.
SK3 Group Inc. (PINK:SKTO) has lost 4.35% or $0.0003 to settle at $0.0066 with a volume of 13.9 million shares. The stock has been trading above its 50 day moving average of $0.0053 and its 200 day moving average of $0.0044 with a relative strength index of 54.2.
SK3 Group, Inc. (SK3), formerly CTT International Distributors Inc., is a development-stage company. The Company was formed by the merger of Slabsdirect.com, Inc. and CTT International Distributors Inc. SK3 has one subsidiary, CTT Distributors Ltd., which is the operating company.
Calypte Biomedical (PINK:CBMC) has gained 246% or two cents a share to settle at $0.0225. The stock has been trading above its 50 day moving average of $0.0059 and its 200 day moving average of $0.0067 with a relative strength index of 90.
Calypte Biomedical Corporation develops, manufactures, and distributes in vitro diagnostic tests, primarily for the diagnosis of Human Immunodeficiency Virus (HIV) infection. It is focused on the development and commercialization of the Aware HIV-1/2 rapid tests. Its product line includes the Aware line of rapid tests, the Aware HIV-1 BED Incidence test and the Aware Messenger specimen collection device.
MultiCell Technologies (OTCBB:MCET) has lost 11.86% or $0.0007 to settle at $0.0052 with a volume of 10.4 million shares. The stock recently had a bullish momentum crossover of its 50 day moving average of $0.0063 crossing over its 200 day moving average of $0.0061 with a relative strength index of 37.
MultiCell Technologies, Inc. (MultiCell) is an integrated biopharmaceutical company. The Company is engaged in pursuing research and development targeting degenerative neurological diseases, including multiple sclerosis (MS) and cancer. As of November 30, 2009, the Company's portfolio of drug candidates, which were in various stages of preclinical and clinical development included MCT-125, MCT-465 and MCT-475.
Energyconnect Group (OTCBB:ECNG) has exploded 62.79% or eight cents a share to settle at $.21 with a surging volume of 9.4 million shares, compared to its average three-month volume of 84,000 shares. For the past 52 weeks the stock has been trading between eight cents a share and $.26 a share, and is currently trading with a market cap of $28 million.
EnergyConnect Group, Inc. is a provider of demand response services to the electricity grid. Demand response programs provide grid operators with additional electricity generation capacity by encouraging consumers to curtail their electricity usage. Demand response programs fall into two main groups, programs made for customers to stand by and respond to a grid event initiated by the grid operator, and programs that rely on customers curtailing their use of electricity based upon price signals.
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. Always do you own homework before investing in any stock.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCpicks.com has not been compensated for any current or recent stocks listed in this stock news report
